| 2.16 -0.365 (-14.46%) | 12-15 15:26 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.87 |
1-year : | 3.57 |
| Resists | First : | 2.46 |
Second : | 3.05 |
| Pivot price | 2.36  |
|||
| Supports | First : | 1.49 |
Second : | 1.23 |
| MAs | MA(5) : | 2.63 |
MA(20) : | 2.19 |
| MA(100) : | 2.61 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 59.7 |
D(3) : | 74.9 |
| RSI | RSI(14): 45.5 |
|||
| 52-week | High : | 15.77 | Low : | 1.49 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ VTAK ] has closed above bottom band by 34.8%. Bollinger Bands are 38% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.77 - 2.79 | 2.79 - 2.8 |
| Low: | 2.44 - 2.46 | 2.46 - 2.48 |
| Close: | 2.5 - 2.53 | 2.53 - 2.55 |
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.
Wed, 03 Dec 2025
Catheter Precision (VTAK) Secures Groundbreaking VIVO System Ten - GuruFocus
Tue, 25 Nov 2025
CMS ASC EP ablation codes in 2026 open LockeT path, Catheter Precision (VTAK) - Stock Titan
Thu, 13 Nov 2025
Catheter Precision (VTAK) Reports Third Quarter and First Nine Months 2025 Results of Operations - Yahoo Finance
Tue, 30 Sep 2025
Catheter Precision, Inc. Announces Two New Patents to be Issued by USPTO - GlobeNewswire
Mon, 18 Aug 2025
Why Is Catheter Precision Stock (VTAK) Up 70% Today? - TipRanks
Mon, 18 Aug 2025
Why Did Catheter Precision Stock Soar 49% Today? - Stocktwits
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|